These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1141 related items for PubMed ID: 30182951

  • 1. Calycosin, a Phytoestrogen Isoflavone, Induces Apoptosis of Estrogen Receptor-Positive MG-63 Osteosarcoma Cells via the Phosphatidylinositol 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Sun H, Yin M, Qian W, Yin H.
    Med Sci Monit; 2018 Sep 05; 24():6178-6186. PubMed ID: 30182951
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor efficacy of phellamurin in osteosarcoma cells: Involvement of the PI3K/AKT/mTOR pathway.
    Zhang H, Jiang H, Zhang H, Liu J, Hu X, Chen L.
    Eur J Pharmacol; 2019 Sep 05; 858():172477. PubMed ID: 31228450
    [Abstract] [Full Text] [Related]

  • 3. Calycosin induces apoptosis in osteosarcoma cell line via ERβ‑mediated PI3K/Akt signaling pathways.
    Tian W, Wang ZW, Yuan BM, Bao YG.
    Mol Med Rep; 2020 Jun 05; 21(6):2349-2356. PubMed ID: 32236598
    [Abstract] [Full Text] [Related]

  • 4. Anti-tumoral potential of MDA19 in human osteosarcoma via suppressing PI3K/Akt/mTOR signaling pathway.
    Liu B, Xu L, Dai EN, Tian JX, Li JM.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30442873
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA‑22 mediates the cisplatin resistance of osteosarcoma cells by inhibiting autophagy via the PI3K/Akt/mTOR pathway.
    Meng CY, Zhao ZQ, Bai R, Zhao W, Wang YX, Xue HQ, Sun L, Sun C, Feng W, Guo SB.
    Oncol Rep; 2020 Apr 21; 43(4):1169-1186. PubMed ID: 32323781
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene.
    Li KW, Wang SH, Wei X, Hou YZ, Li ZH.
    Eur Rev Med Pharmacol Sci; 2020 Dec 21; 24(24):12655-12666. PubMed ID: 33378012
    [Abstract] [Full Text] [Related]

  • 7. Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 against osteosarcoma.
    Zhu YR, Min H, Fang JF, Zhou F, Deng XW, Zhang YQ.
    Cancer Biol Ther; 2015 Dec 21; 16(4):602-9. PubMed ID: 25869769
    [Abstract] [Full Text] [Related]

  • 8. Antineoplastic effect of calycosin on osteosarcoma through inducing apoptosis showing in vitro and in vivo investigations.
    Qiu R, Ma G, Zheng C, Qiu X, Li X, Li X, Mo J, Li Z, Liu Y, Mo L, Bi G, Ye Y.
    Exp Mol Pathol; 2014 Aug 21; 97(1):17-22. PubMed ID: 24797937
    [Abstract] [Full Text] [Related]

  • 9. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression.
    Aoki Y, Kubota Y, Masaki N, Obara K, Tome Y, Bouvet M, Nishida K, Hoffman RM.
    Anticancer Res; 2024 Jul 21; 44(7):2787-2792. PubMed ID: 38925854
    [Abstract] [Full Text] [Related]

  • 10. Calycosin induces apoptosis in colorectal cancer cells, through modulating the ERβ/MiR-95 and IGF-1R, PI3K/Akt signaling pathways.
    Zhao X, Li X, Ren Q, Tian J, Chen J.
    Gene; 2016 Oct 10; 591(1):123-128. PubMed ID: 27393650
    [Abstract] [Full Text] [Related]

  • 11. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
    Li Y, Hu S, Chen Y, Zhang X, Gao H, Tian J, Chen J.
    Phytomedicine; 2023 Sep 10; 118():154924. PubMed ID: 37393829
    [Abstract] [Full Text] [Related]

  • 12. RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway.
    Liu M, Qi Z, Liu B, Ren Y, Li H, Yang G, Zhang Q.
    Oncotarget; 2015 Sep 22; 6(28):25281-94. PubMed ID: 26325371
    [Abstract] [Full Text] [Related]

  • 13. Diallyl trisulfide regulates cell apoptosis and invasion in human osteosarcoma U2OS cells through regulating PI3K/AKT/GSK3β signaling pathway.
    He P, Wang Z, Sheng B, Xu Y, Feng S, Huang Y, Gong F, Tang L, Xie L.
    Histol Histopathol; 2020 Dec 22; 35(12):1511-1520. PubMed ID: 33372687
    [Abstract] [Full Text] [Related]

  • 14. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway.
    Liu F, Gao S, Yang Y, Zhao X, Fan Y, Ma W, Yang D, Yang A, Yu Y.
    Oncol Rep; 2018 Mar 22; 39(3):1523-1531. PubMed ID: 29328421
    [Abstract] [Full Text] [Related]

  • 15. Aclidinium bromide inhibits proliferation of osteosarcoma cells through regulation of PI3K/Akt pathway.
    Li ZZ, Wang YL, Yu YH, Xing YL, Ji XF.
    Eur Rev Med Pharmacol Sci; 2019 Jan 22; 23(1):105-112. PubMed ID: 30657552
    [Abstract] [Full Text] [Related]

  • 16. Licochalcone A induces autophagy through PI3K/Akt/mTOR inactivation and autophagy suppression enhances Licochalcone A-induced apoptosis of human cervical cancer cells.
    Tsai JP, Lee CH, Ying TH, Lin CL, Lin CL, Hsueh JT, Hsieh YH.
    Oncotarget; 2015 Oct 06; 6(30):28851-66. PubMed ID: 26311737
    [Abstract] [Full Text] [Related]

  • 17. Deoxyshikonin isolated from Arnebia euchroma inhibits colorectal cancer by down-regulating the PI3K/Akt/mTOR pathway.
    Zhu Y, Zhong Y, Long X, Zhu Z, Zhou Y, Ye H, Zeng X, Zheng X.
    Pharm Biol; 2019 Dec 06; 57(1):412-423. PubMed ID: 31230505
    [Abstract] [Full Text] [Related]

  • 18. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
    Niu NK, Wang ZL, Pan ST, Ding HQ, Au GH, He ZX, Zhou ZW, Xiao G, Yang YX, Zhang X, Yang T, Chen XW, Qiu JX, Zhou SF.
    Drug Des Devel Ther; 2015 Dec 06; 9():1555-84. PubMed ID: 25792811
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of Prostate Cancer DU-145 Cells Proliferation by Anthopleura anjunae Oligopeptide (YVPGP) via PI3K/AKT/mTOR Signaling Pathway.
    Li X, Tang Y, Yu F, Sun Y, Huang F, Chen Y, Yang Z, Ding G.
    Mar Drugs; 2018 Sep 11; 16(9):. PubMed ID: 30208576
    [Abstract] [Full Text] [Related]

  • 20. Antitumor activity of pimasertib, a selective MEK 1/2 inhibitor, in combination with PI3K/mTOR inhibitors or with multi-targeted kinase inhibitors in pimasertib-resistant human lung and colorectal cancer cells.
    Martinelli E, Troiani T, D'Aiuto E, Morgillo F, Vitagliano D, Capasso A, Costantino S, Ciuffreda LP, Merolla F, Vecchione L, De Vriendt V, Tejpar S, Nappi A, Sforza V, Martini G, Berrino L, De Palma R, Ciardiello F.
    Int J Cancer; 2013 Nov 11; 133(9):2089-101. PubMed ID: 23629727
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.